Market Overview:
The global ergosterol market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for ergosterol from the pharmaceutical and chemical industries. Ergosterol is used as a target for antifungal drugs and antiprotozoal drugs, which has led to an increase in its demand. Additionally, the growing awareness about the benefits of ergosterol is also contributing to its growth. The global ergosterol market by type is segmented into target for antifungal drugs, target for antiprotozoal drugs, and other types. The target for antifungal drug segment accounted for the largest share of the global ergosterol market in 2017 and is projected to grow at a CAGR of 5.8% during 2018-2030 owing to rising prevalence of fungal infections across globe coupled with increasing use of fungicides in agriculture sector .
Product Definition:
ergosterol ( ˈɜːrgəstᵻrɒl ) n ( biochemistry ) a sterol found in the cell membranes of fungi.
Target for Antifungal Drugs:
Antifungal drugs are used to treat fungal infections caused by yeast-like fungi called aspergilli or Candida. Aspergillus is the most common cause of invasive fungal disease, affecting both animals and people. The other two main causes of fungally induced diseases are filamentous fungi (e.g., Trichoderma harzianum) and basidiomycetes (e.g., Blastomyces dermatitidis).
Target for Antiprotozoal Drugs:
The target for anti-protozoal drugs is the 30S and 50S subunit of ?-galactosidase. The presence of this enzyme in the body fluids (such as urine, blood, and milk) drives the pathogenetic process. Targeted drug therapy aims to reduce or eliminate these enzymes from infected cells by inhibiting their activity with an inhibitor or destroying them completely with an active agent.
Application Insights:
The medicine segment dominated the global ergosterol market in 2017. The medicinal properties of ergosterol have been known for centuries and it is widely used as a standard drug for various diseases. It is available in different forms such as emulsified oil, ointment, capsule and powder which are easy to administer. Moreover, its ability to prevent fungal growth on human skin has increased its demand as an antifungal agent across the globe. However, high manufacturing costs restrict its use only in medicines thus leading to low consumption rates overall compared with other applications segments such as chemical industry or others.
Chemical industry segment is expected to grow at a significant rate over the forecast period owing to increasing usage of ergosterol-based chemicals across several industries including paints & coatings.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing geriatric population, which is prone to various infectious diseases. In addition, rising healthcare expenditure by governments and an increase in per capita income are some of the major factors that can be attributed for regional growth.
The presence of a large number of target disease entities such as cancer, diabetes & obesity, arthritis & other autoimmune diseases has led North America to grow at a significant rate over the past few years.
Growth Factors:
- Increasing awareness about the health benefits of ergosterol is expected to drive the market growth.
- Rising demand for natural and organic products is another key factor that is anticipated to fuel the market growth in the near future.
- Growing inclination of consumers towards preventive healthcare is also projected to boost the demand for ergosterol over the forecast period.
- Increasing research and development activities for new applications of ergosterol are likely to create lucrative opportunities for market players in years ahead.
- Growing popularity of dietary supplements is anticipated to propel demand for ergosterol over forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Ergosterol Market Research Report
By Type
Target for Antifungal Drugs, Target for Antiprotozoal Drugs, Other
By Application
Medicine, Chemical Industry, Others
By Companies
Chengdu Yazhong Bio-pharmaceutical, ZELANG, Guangzhou Wuzhou Pharmaceutical, AURUM Pharmatech LLC, RGT, HSF, Wilmar, Rokey, VS, Sumitomo Chemical, Sichuan Neijiang Hui Xin Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Ergosterol Market Report Segments:
The global Ergosterol market is segmented on the basis of:
Types
Target for Antifungal Drugs, Target for Antiprotozoal Drugs, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medicine, Chemical Industry, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Chengdu Yazhong Bio-pharmaceutical
- ZELANG
- Guangzhou Wuzhou Pharmaceutical
- AURUM Pharmatech LLC
- RGT
- HSF
- Wilmar
- Rokey
- VS
- Sumitomo Chemical
- Sichuan Neijiang Hui Xin Pharmaceutical
Highlights of The Ergosterol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Target for Antifungal Drugs
- Target for Antiprotozoal Drugs
- Other
- By Application:
- Medicine
- Chemical Industry
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ergosterol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ergosterol is a type of cholesterol found in plants. It is thought to play an important role in plant growth and defense.
Some of the major companies in the ergosterol market are Chengdu Yazhong Bio-pharmaceutical, ZELANG, Guangzhou Wuzhou Pharmaceutical, AURUM Pharmatech LLC, RGT, HSF, Wilmar, Rokey, VS, Sumitomo Chemical, Sichuan Neijiang Hui Xin Pharmaceutical.
The ergosterol market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ergosterol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ergosterol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ergosterol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ergosterol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ergosterol Market Size & Forecast, 2018-2028
4.5.1 Ergosterol Market Size and Y-o-Y Growth
4.5.2 Ergosterol Market Absolute $ Opportunity
Chapter 5 Global Ergosterol Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ergosterol Market Size Forecast by Type
5.2.1 Target for Antifungal Drugs
5.2.2 Target for Antiprotozoal Drugs
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ergosterol Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ergosterol Market Size Forecast by Applications
6.2.1 Medicine
6.2.2 Chemical Industry
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ergosterol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ergosterol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ergosterol Analysis and Forecast
9.1 Introduction
9.2 North America Ergosterol Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ergosterol Market Size Forecast by Type
9.6.1 Target for Antifungal Drugs
9.6.2 Target for Antiprotozoal Drugs
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ergosterol Market Size Forecast by Applications
9.10.1 Medicine
9.10.2 Chemical Industry
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ergosterol Analysis and Forecast
10.1 Introduction
10.2 Europe Ergosterol Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ergosterol Market Size Forecast by Type
10.6.1 Target for Antifungal Drugs
10.6.2 Target for Antiprotozoal Drugs
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ergosterol Market Size Forecast by Applications
10.10.1 Medicine
10.10.2 Chemical Industry
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ergosterol Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ergosterol Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ergosterol Market Size Forecast by Type
11.6.1 Target for Antifungal Drugs
11.6.2 Target for Antiprotozoal Drugs
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ergosterol Market Size Forecast by Applications
11.10.1 Medicine
11.10.2 Chemical Industry
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ergosterol Analysis and Forecast
12.1 Introduction
12.2 Latin America Ergosterol Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ergosterol Market Size Forecast by Type
12.6.1 Target for Antifungal Drugs
12.6.2 Target for Antiprotozoal Drugs
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ergosterol Market Size Forecast by Applications
12.10.1 Medicine
12.10.2 Chemical Industry
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ergosterol Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ergosterol Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ergosterol Market Size Forecast by Type
13.6.1 Target for Antifungal Drugs
13.6.2 Target for Antiprotozoal Drugs
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ergosterol Market Size Forecast by Applications
13.10.1 Medicine
13.10.2 Chemical Industry
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ergosterol Market: Competitive Dashboard
14.2 Global Ergosterol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Chengdu Yazhong Bio-pharmaceutical
14.3.2 ZELANG
14.3.3 Guangzhou Wuzhou Pharmaceutical
14.3.4 AURUM Pharmatech LLC
14.3.5 RGT
14.3.6 HSF
14.3.7 Wilmar
14.3.8 Rokey
14.3.9 VS
14.3.10 Sumitomo Chemical
14.3.11 Sichuan Neijiang Hui Xin Pharmaceutical
